Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Lipocine Inc. (LPCN)

« Back to company index

LPCN Chatter Timeline

Stock Ticker for LPCN

Most Active Tweeters for LPCN

UserTweets
@dispatchtribune 2
@TickerReport 2
@AlertTrade 1
@richardsgibb1 1
@EnterpriseLeade 1

Recent Tweets for LPCN

StockNewsNow @StockNewsNow
$LPCN Lipocine to Participate in the Oppenheimer & Co. Fall Summit Focused on Specialty Pharma, Rare Disease & Gene… https://t.co/ZBOnYQ1hUt
12:09pm
newswithvalue @newswithvalue
$LPCN: Lipocine to Participate in the Oppenheimer & Co. Fall Summit …: https://t.co/8JABEoDQhs
8:09am
WatchlistN @WatchlistN
Analysts Expect Lipocine Inc $LPCN Will Announce Earnings of -$0.23 Per Share https://t.co/83VPligsHK
September 15th 2019, 7:09pm
richardsgibb1 @richardsgibb1
$lpcn, sold my holding the other day and miraculously hit the very top for $1.50 share gain. Started buying again a… https://t.co/Otz4Enn7R5
September 12th 2019, 10:09am
AlertTrade @AlertTrade
TREND REVERSAL DOWN ALERT: $LPCN Lipocine, Inc ? TradeIdeas via https://t.co/VS8RO1bzXJ to FREE Trading Room
September 11th 2019, 2:09pm
TickerReport @TickerReport
Zacks: Analysts Expect Lipocine Inc $LPCN Will Announce Earnings of -$0.23 Per Share https://t.co/wwOfVb938r
September 10th 2019, 10:09am
dispatchtribune @dispatchtribune
Zacks: Analysts Expect Lipocine Inc $LPCN Will Announce Earnings of -$0.23 Per Share https://t.co/qu5lLkFA36
September 10th 2019, 10:09am
AmericanBanking @AmericanBanking
Zacks: Analysts Expect Lipocine Inc $LPCN Will Announce Earnings of -$0.23 Per Share https://t.co/P5bWPavi8i #stocks
September 10th 2019, 10:09am
bkfViking123 @bkfViking123
bullish action ..... waiting for the long green candle. $lpcn
September 9th 2019, 7:09pm
ahighelevation @ahighelevation
Counting down to target action date... $LPCN #biotech https://t.co/UwtvrSEb0p https://t.co/80JCH6rINf
September 8th 2019, 7:09pm
registrarjourn @registrarjourn
Lipocine $LPCN Stock Rating Lowered by ValuEngine https://t.co/KPAedZUWDr
September 8th 2019, 10:09am
EnterpriseLeade @EnterpriseLeade
Lipocine $LPCN Stock Rating Lowered by ValuEngine https://t.co/XVsExMpmxe
September 8th 2019, 10:09am
dispatchtribune @dispatchtribune
Lipocine $LPCN Stock Rating Lowered by ValuEngine https://t.co/5scGyDo3XS
September 8th 2019, 10:09am
TickerReport @TickerReport
Lipocine $LPCN Stock Rating Lowered by ValuEngine https://t.co/i7oLHYc4GH
September 7th 2019, 5:09pm
Gambiste1 @Gambiste1
RT @ChartMill: $LPCN is one of the better performing stocks in the Drugs industry. https://t.co/83i17ZGIRA https://t.co/xtPGl7oRVa
August 8th 2019, 4:08am
ChartMill @ChartMill
$LPCN is one of the better performing stocks in the Drugs industry. https://t.co/83i17ZGIRA https://t.co/xtPGl7oRVa
August 8th 2019, 2:08am
Gambiste1 @Gambiste1
RT @MarketCurrents: $LPCN - Lipocine EPS beats by $0.07 https://t.co/dl3RJZ7znt
August 7th 2019, 7:08pm
StockNewsNow @StockNewsNow
$LPCN Lipocine Announces Second Quarter 2019 Financial and Operational Results https://t.co/h3fdvRxWAA
August 7th 2019, 1:08pm
StockNewsWires @StockNewsWires
$LPCN: Lipocine Announces Second Quarter 2019 Financial and …: https://t.co/EFsQzROqDI
August 7th 2019, 8:08am
MarketCurrents @MarketCurrents
$LPCN - Lipocine EPS beats by $0.07 https://t.co/dl3RJZ7znt
August 7th 2019, 8:08am
confcalltran @confcalltran
Lipocine Announces Second Quarter 2019 Financial And Operational Results https://t.co/cQZyWRk051 $LPCN
August 7th 2019, 8:08am
confcalltran @confcalltran
Lipocine Inc. Just Filed Its Quarterly Report:   ... https://t.co/qHvwkgbyGd $LPCN
August 7th 2019, 8:08am
smallcapwatch @smallcapwatch
RT @ahighelevation: $LPCN Low T Tied to Multiple Ailments #biotech #smallcap #biostock https://t.co/uR1ol0ht6T https://t.co/PglM11NmdO
August 6th 2019, 2:08pm
ahighelevation @ahighelevation
$LPCN Low T Tied to Multiple Ailments #biotech #smallcap #biostock https://t.co/uR1ol0ht6T https://t.co/PglM11NmdO
August 6th 2019, 2:08pm
Gambiste1 @Gambiste1
RT @ZacksSmallCap: New TRT Launch Signals Receptive Environment $LPCN #biotech @vanjohn10 #smallcap https://t.co/wJwKyIKtFF https://t.co/A4…
August 5th 2019, 4:08pm
ZacksSmallCap @ZacksSmallCap
New TRT Launch Signals Receptive Environment $LPCN #biotech @vanjohn10 #smallcap https://t.co/wJwKyIKtFF https://t.co/A4Dvgr6R1Y
August 5th 2019, 1:08pm
ZolmaxNews @ZolmaxNews
Lipocine $LPCN Stock Passes Below 50 Day Moving Average of $1.84 https://t.co/IasBYLrSHH
August 3rd 2019, 9:08pm
WatchlistN @WatchlistN
Lipocine $LPCN Stock Passes Below 50 Day Moving Average of $1.84 https://t.co/MLJOEvw0Yi
August 3rd 2019, 9:08pm
dailypoliticaln @dailypoliticaln
Lipocine $LPCN Stock Price Passes Below 50 Day Moving Average of $1.84 https://t.co/QaHK6g9jug
August 3rd 2019, 9:08pm
1stOncology @1stOncology
#Lipocine to Present at the Canaccord Genuity 39th Annual Growth Conference $LPCN https://t.co/Ql9znrCYxV
August 2nd 2019, 6:08am
macondailynews @macondailynews
Lipocine $LPCN Shares Cross Below Fifty Day Moving Average of $1.84 https://t.co/Qmn01eyyum
August 1st 2019, 11:08pm
TheMarketsDaily @TheMarketsDaily
Lipocine $LPCN Stock Crosses Below Fifty Day Moving Average of $1.84 https://t.co/01KrVDLwsQ
August 1st 2019, 11:08pm
stocknewstimes @stocknewstimes
Lipocine $LPCN Shares Cross Below Fifty Day Moving Average of $1.84 https://t.co/rru1XFTmmb
August 1st 2019, 11:08pm
LifeSciAdvisors @LifeSciAdvisors
Lipocine $LPCN to Present at the Canaccord Genuity 39th Annual Growth Conference https://t.co/wIsIAJECSW
July 30th 2019, 2:07pm
ahighelevation @ahighelevation
$LPCN New TRT Launch Signals Receptive Environment #biotech https://t.co/7VwFAMsp5i https://t.co/yaWbd5vpQE
July 30th 2019, 1:07pm
StockNewsNow @StockNewsNow
$LPCN Lipocine to Present at the Canaccord Genuity 39th Annual Growth Conference https://t.co/jqgFFfZYK4
July 30th 2019, 12:07pm
newswelldone @newswelldone
$LPCN: Lipocine to Present at the Canaccord Genuity 39th Annual Growth …: https://t.co/8aiQlDhRwt
July 30th 2019, 8:07am
vanjohn10 @vanjohn10
$LPCN to present at Canaccord Genuity Growth Conference 8AUG19 in Boston @ 1:00 pm local. https://t.co/DUUiPt3NaI
July 30th 2019, 8:07am
Gambiste1 @Gambiste1
RT @ZacksSmallCap: $LPCN: Low T Tied to Multiple Ailments https://t.co/3I9OJ8YQa9 by @vanjohn10 https://t.co/YKXSacV7R2
July 29th 2019, 6:07pm
ZacksSmallCap @ZacksSmallCap
$LPCN: Low T Tied to Multiple Ailments https://t.co/3I9OJ8YQa9 by @vanjohn10 https://t.co/YKXSacV7R2
July 29th 2019, 9:07am
dispatchtribune @dispatchtribune
Lipocine $LPCN Trading Up 1.1% https://t.co/bq9TbIHEO6
July 25th 2019, 2:07pm
registrarjourn @registrarjourn
Lipocine $LPCN Shares Up 1.1% https://t.co/wJIjrn9Ze0
July 25th 2019, 2:07pm
EnterpriseLeade @EnterpriseLeade
Lipocine $LPCN Shares Up 1.1% https://t.co/z7Z4ts49VM
July 25th 2019, 2:07pm
LifeSciAdvisors @LifeSciAdvisors
Lipocine $LPCN Receives FDA Clearance for Clinical Testing its NASH Candidate, LPCN 1144, in Expanded Target Popula… https://t.co/ZRrjcb19o9
July 23rd 2019, 5:07pm
MaisaCorp @MaisaCorp
$LPCN Gets FDA OK to Expand Clinical Test Liver Disease Treatment Candidate
July 23rd 2019, 3:07pm
StockNewsNow @StockNewsNow
$LPCN Lipocine Receives FDA Clearance for Clinical Testing its NASH Candidate, LPCN 1144, in Expanded Target Popula… https://t.co/G4agGcwvT1
July 23rd 2019, 11:07am
NewsToDesk @NewsToDesk
$LPCN: FDA OKs expanded population for Lipocine’s NASH candidate …: https://t.co/TXtQono5zg
July 23rd 2019, 9:07am
MarketCurrents @MarketCurrents
$LPCN - FDA OKs expanded population for Lipocine's NASH candidate LPCN 1144 https://t.co/OYjGZ6gc0G
July 23rd 2019, 8:07am
bkfViking123 @bkfViking123
$LPCN next ..... been banging the table on this one https://t.co/8NdUOmn4eu
July 23rd 2019, 8:07am
vanjohn10 @vanjohn10
$LPCN receives FDA clearance to expand LPCN 1144 studies to include NASH subjects above hypogonadal levels. Could e… https://t.co/PU7e2zWmGg
July 23rd 2019, 8:07am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.